Peritoneal Dialysis Complication, Sarcopenic Obesity
Conditions
Brief summary
In this study, it was aimed to evaluate the effectiveness of medical nutrition therapy to be applied to patients with sarcopenic obesity receiving peritoneal dialysis treatment by measuring anthropometric measurements and blood parameters.
Detailed description
Efficacy of medical nutrition therapy in patients with sarcopenic obesity receiving peritoneal dialysis treatment, general information form after patients filled in the voluntary consent form, SARC-F questionnaire as sarcopenia screening test, International Physical Activity Questionnaire (IPAQ), muscle mass, muscle strength, physical performance, BIA measurement, anthropometric measurements, laboratory findings and three-day food consumption records will be evaluated.
Interventions
OTHERmedical nutrition therapy in kidney diseases
Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates
Sponsors
Atlas University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Volunteering to participate in research * Be between the ages of 18-70 * To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment
Exclusion criteria
* Presence of any other disease that causes muscle wasting * Patients using any supplement or enteral product in their diet
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in muscle strength | Baseline to 3 months after diet programme | Handgrip strength (kg) will be measured by using the CAMRY EH101 dynamometer. Hand grip strength \<16 kg for women and \<27 kg for men indicates low muscle strength. |
| Change in the skeletal muscle mass | Baseline to 3 months after diet programme | Skeletal muscle mass (kg) will be measured by using bioelectrical impedance analysis. |
| Change in the physical performance | Baseline to 3 months after diet programme | 4-meter walking speed test will be performed. A walking speed of ≤0.8 m/sec is considered as an indicator of severe sarcopenia. |
| Change of the fat mass | Baseline to 3 months after diet programme | Fat mass (kg) will be measured by using bioelectrical impedance analysis. |
| Changes of percentage of body fat | Baseline to 3 months after diet programme | Percentage of body fat will be measured by using bioelectrical impedance analysis. |
| Changes of body mass index | Baseline to 3 months after diet programme | The weight and height will be combined to report BMI in kg/m2. |
Countries
Turkey (Türkiye)
Outcome results
None listed